295 related articles for article (PubMed ID: 18226262)
1. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.
Saunders DL; Chaorattanakawee S; Gosi P; Lanteri C; Somethy S; Kuntawunginn W; Ittiverakul M; Chann S; Gregory C; Chuor CM; Prom S; Spring MD; Lon C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1896-8. PubMed ID: 26711753
[TBL] [Abstract][Full Text] [Related]
4. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
[TBL] [Abstract][Full Text] [Related]
5. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
6. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
[TBL] [Abstract][Full Text] [Related]
8. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
9. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
[TBL] [Abstract][Full Text] [Related]
10. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
[TBL] [Abstract][Full Text] [Related]
11. Selection of Cytochrome
Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.
Ingasia LA; Akala HM; Imbuga MO; Opot BH; Eyase FL; Johnson JD; Bulimo WD; Kamau E
Antimicrob Agents Chemother; 2015 Mar; 59(3):1818-21. PubMed ID: 25583715
[TBL] [Abstract][Full Text] [Related]
13. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
[TBL] [Abstract][Full Text] [Related]
14. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S
J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK
J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722
[TBL] [Abstract][Full Text] [Related]
17. Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol.
L'Episcopia M; Kelley J; Patel D; Schmedes S; Ravishankar S; Menegon M; Perrotti E; Nurahmed AM; Talha AA; Nour BY; Lucchi N; Severini C; Talundzic E
Parasit Vectors; 2020 Mar; 13(1):137. PubMed ID: 32171330
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
[TBL] [Abstract][Full Text] [Related]
19. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
[No Abstract] [Full Text] [Related]
20. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
Fivelman QL; Butcher GA; Adagu IS; Warhurst DC; Pasvol G
Malar J; 2002 Feb; 1():1. PubMed ID: 12057021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
